38450 Federal Register / Vol. 74, No. 147 / Monday, August 3, 2009 / Notices 

page limitations. Submissions exceeding 

this limit will not be accepted and will 

be returned. Oral testimony of this 

material at the meeting will be limited 

to no more than 5–6 minutes in length. 

Because of time constraints for oral 

testimony, testifiers may not be able to 

present the complete information as it is 

contained in their written form 

submitted for inclusion in the public 

record for the meeting. Therefore, 

testifiers are requested to summarize the 

major points of emphasis from the 

written testimony, not to exceed 6 

minutes of oral testimony. Those 

individuals or organizations that have 

indicated they will present oral 

testimony at the meeting in Providence 

will be notified prior to the meeting 

regarding the approximate time for their 

oral presentation. 

Individuals and organizations wishing 

to provide written statements only 

should send a copy of their statements, 

electronically or by mail, to the above 

Web site or address by September 13, 

2009. Written testimony received by 

that date will be made available at the 

September 21–23 meeting. Logistics 

questions related to this meeting should 

be addressed to Ms. Jory Barone at ESI, 

while program-specific questions 

should be addressed to Ms. Maureen 

Pearlman at the Warren Alpert Medical 

School of Brown University, 

Providence, Rhode Island, 401–276– 

7800, ext. 123, mpearlman@wihri.org. 

At the conclusion of the regional 

meetings, the ORWH will hold a 

meeting at the NIH to summarize the 

deliberations from the regional 

conferences. The resulting report to the 

ORWH and the NIH will ensure that 

women’s health research in the coming 

decade continues to support a vigorous 

research agenda incorporating the latest 

advances in technology and cuttingedge science. 

Dated: July 28, 2009. 

Raynard S. Kington, 

Acting Director, National Institutes of Health. 

[FR Doc. E9–18535 Filed 7–31–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

President’s Cancer Panel. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: President’s Cancer 

Panel. 

Date: September 22, 2009. 

Time: 8 a.m. to 4:10 p.m. 

Agenda: America’s Demographic and 

Cultural Transformation: Implications for the 

Cancer Enterprise. 

Place: The Westin Seattle, 1900 Fifth 

Avenue, Seattle, WA 98101. 

Contact Person: Abby B. Sandler, PhD, 

Executive Secretary, Chief, Institute Review 

Office, Office of the Director, 6116 Executive 

Blvd., Suite 220, MSC 8349, National Cancer 

Institute, NIH, Bethesda, MD 20892–8349. 

(301) 451–9399. sandlera@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: 

deainfo.nci.nih.gov/advisory/pcp/pcp.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: July 28, 2009. 

Anna Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–18531 Filed 7–31–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

National Advisory Council for 

Biomedical Imaging and Bioengineering. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Council for Biomedical Imaging and 

Bioengineering. NACBIB, September 2009. 

Date: September 11, 2009. 

Open: 9 a.m. to 1 p.m. 

Agenda: Report from the Institute Director, 

other Institute Staff and presentations of 

working group reports. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Closed: 1 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Anthony Demsey, PhD, 

Director, National Institute of Biomedical 

Imaging, and Bioengineering, 6701 

Democracy Boulevard, Room 241, Bethesda, 

MD 20892. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.nibib1.nih.gov/about/NACBIB/ 

NACBIB.htm, where an agenda and any 

additional information for the meeting will 

be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.701, ARRA Related 

Biomedical Research and Research Support 

Awards. National Institutes of Health, HHS) 

Dated: July 28, 2009. 

Anna Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–18529 Filed 7–31–09; 8:45 am] 

BILLING CODE 4140–01–P 


sroberts on DSKD5P82C1PROD with NOTICES